Increased production of tumor necrosis factor-α by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells

Journal of Neuroscience

Volumn 20, Issue 23, 2000, Pages 8693-8700

  Tezel, G ^a   Wax, M B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Glaucoma; Glia; Nitric oxide; Retinal ganglion cell; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; GLAUCOMA; HYDROSTATIC PRESSURE; NONHUMAN; OPTIC NERVE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; RETINA ISCHEMIA;

EID: 0034548875     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-23-08693.2000     Document Type: Article

References (66)

1. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve
2. Tumor necrosis factor-α. A mediator of focal ischemic brain injury
3. Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning
4. Nitric oxide: A physiologic messenger molecule
5. Stimulation of tumor necrosis factor-α production by mycoplasma and inhibition by dexamethasone in cultured astrocytes
6. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serumfree medium combination
7. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury
8. Vascular aspects in the pathophysiology of glaucomatous optic neuropathy
9. Tumor necrosis factor and nitric oxide production by retinal M∫ller glial cells from rats exhibiting inherited retinal dystrophy
10. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures
11. Tumor necrosis factor and nitric oxide production by resident retinal glial cells from rats presenting hereditary retinal degeneration
12. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T-cell traffic to the retina
13. Neuronal death in cytokine-activated primary human brain cell culture: Role of tumor necrosis factor-α
14. Glia modulate the response of murine cortical neurons to excitotoxicity: Glia exacerbate AMPA neurotoxicity
15. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome
16. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL
17. The vascular concept of glaucoma
18. 1400W is a slow, tight-binding and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo
19. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
20. Control of nitric oxide production by endogenous TNF-α in mouse retinal pigmented epithelial and M∫ller glial cells
21. Requirement for nitric oxide in retinal neuronal cell death induced by activated M∫ller glial cells
22. Multivariate analysis of the risk of glaucomatous visual field loss
23. Handbook of fluorescent probes and research chemicals, 5th ed, pp
24. Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma, and allied disorders
25. Induction of nitric oxide synthase nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-α/lipopolysaccharide
26. The optic nerve head in glaucomatous optic neuropathy
27. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS
28. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
29. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage
30. Ciliary neurotrophic factor is an axogenesis factor for retinal ganglion cells
31. Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells
32. Nitric oxide synthase (NOS) inhibitors ameliorate retinal damage induced by ischemia in rats
33. Circulating antibody against tumor necrosis factor-α protects rat brain from reperfusion injury
34. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus
35. An immunohistochemical study of TNF-α in optic nerves from AIDS patients
36. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: Role of IL-1β and IL-1 receptor antagonist
37. Tumor necrosis factor-α expression in ischemic neurons
38. Tumor necrosis factor-α (TNF-α)-induced optic neuropathy in rabbits
39. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons
40. Microglia in degenerative neurological disease
41. Activation of microglial cells by β-amyloid protein interferon-γ
42. A light microscopic, autoradiographic study of axoplasmic transport in the optic nerve head during ocular hypotony, increased intraocular pressure, and papilledema
43. Nitric oxide synthase in the human glaucomatous optic nerve head
44. Inhibition of nitric oxide synthase-2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of glaucoma
45. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma
46. Reduction of NOS2 overexpression in rheumatoid arthritis patients with anti-tumor necrosis factor-α monoclonal antibody (cA2)
47. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport
48. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis
49. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms, and cues to physiological function
50. Reactive astrocytes: Cellular and molecular cues to biological function
51. Cytokines and the nervous system. II. Actions and mechanisms of action
52. Anti-tumor necrosis factor-α therapy suppresses the induction of experimental uveoretinitis in mice by inhibiting antigen priming
53. Retinal ganglion cell death after different transient periods of pressure-induced ischemia survival intervals
54. Tumor necrosis factor: A cytokine with multiple biological activity
55. Activated astrocytes induce nitric oxide synthase-2 in cerebral endothelium via tumor necrosis facto-α
56. Inhibition of tumor necrosis-α (TNF-α) activity in rat brain is associated with cerebroprotection after closed head injury
57. Hydrostatic pressure induces expression of interleukin-6 tumor necrosis factor-α mRNA in a chondrocyte-like cell line
58. Pressure-induced apoptosis in human lymphoblasts
59. Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro
60. Density-dependent resistance to apoptosis in retinal cells
61. Glial cells potentiate kainate-induced neuronal death in a motoneuron-enriched spinal coculture system
62. A new concept in neurodegeneration: TNF-α is a silencer of survival signals
63. Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-α
64. Responses of different cell lines from ocular tissues to elevated hydrostatic pressure
65. Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin
66. Matrix metalloproteinases and tumor necrosis factor-α in glaucomatous optic nerve head